Clinical testing using various array comparative genomic hybridization platforms is being incorporated rapidly into cytogenetic testing algorithms. Comprehensive validation of these complex assays ...
In addition to the surprising revelation that our chromosomes harbor fewer genes than originally predicted, the Human Genome Project also unveiled that all individuals share approximately 99.9% of ...
Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...
Background: To apply high throughput technologies (CGH array, Hot Spot Mutations arrays) in daily practice in order to drive patients to tailored targeted therapies. Methods: High resolution ...
With the advent of molecular cytogenetic techniques, such as fluorescence in situ hybridization (FISH), it became possible to more precisely define the extent and the actual DNA sequences involved in ...
Microarray based comparative genomic hybridisation (array CGH) is a new technology with uses developing in various diagnostic areas within the NHS. One important context is the investigation of ...
Agilent Technologies Inc. has announced that scientists using an Agilent custom-designed comparative genomic hybridization (CGH) array have sequenced the entire gene map of a Korean male. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results